India Slashes Cancer Drug Prices by up to 70% as New Caps Take Effect
India’s drug regulator has capped trade margins on 137 anti-cancer medicines, cutting prices by up to 70% and saving patients an estimated ₹3,357 crore a year.
India’s drug regulator has capped trade margins on 137 anti-cancer medicines, cutting prices by up to 70% and saving patients an estimated ₹3,357 crore a year.